Journal
NEURODEGENERATIVE DISEASE MANAGEMENT
Volume 7, Issue 6, Pages 35-40Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/nmt-2017-0040
Keywords
brain; exercise therapy; multiple sclerosis; walking
Categories
Funding
- Biogen Idec
- Merck Serono
- Sanofi Aventis
- Bayer Schering
- Novartis
- Sanofi Genzyme
- Almirall SA (Barcelona, Spain)
Ask authors/readers for more resources
Exercise therapy is a promising nonpharmacological therapy in people with multiple sclerosis (MS). Although exercise training may induce a transient worsening of symptoms in some MS patients, it is generally considered safe and does not increase the risk of relapses. Exercise training can lead to clinically relevant improvements in physical function, but should be considered an adjunct to specific task-based training. Exercise has also shown positive effects on the brain, including improvements in brain volume and cognition. In summary, exercise therapy is a safe and potent nonpharmacological intervention in MS, with beneficial effects on both functional capacity and the brain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available